All In Biotech

Drug Trial Radar · NCT06165965

To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JT-001, JT-002 and JLP-2008

A Randomized, Open-label, Two-sequence, and Two-period Crossover Study to Evaluate the Pharmacokinetics and Safety Between the Administration of JLP-2008 and the Co-admin. of JT-001, and JT-002 for Healthy Subjects in Fasted State

Last checked: Nov 19, 2026Latest source record: Dec 12, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

48

Actual

Start

May 3, 2022

Primary completion

Jun 13, 2022

Study completion Jun 27, 2022

Sponsor

Lead sponsor
Jeil Pharmaceutical Co., Ltd.Industry
Sponsor type
Industry
First posted
Dec 12, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 19 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To evaluate the safety and pharmacokinetic characteristics after the administration of JT-001, JT-002 and JLP-2008

Conditions

  • Healthy Adult

Interventions

  • SGLT2 inhibitorDrug

    SGLT2 dual inhibitor

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. AUC over24H of JLP-2008Time frame: 24 hours
  2. Cmax of JLP-2008Time frame: 24 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Bundang CHA university global clinical trials center Institutional Review Board

    Gyeonggi-do, Bundang-gu, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.